Abaxis, Inc. to Present at the Bank of America Merrill Lynch Animal Health Summit and the Raymond James 39th Annual Institutional Investors Conference

UNION CITY, Calif., Feb. 22, 2018 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care instruments and consumables for the medical and veterinary markets worldwide, announced today that Ross Taylor, Chief Financial Officer, will present at the following investor conferences:

    --  Bank of America Merrill Lynch 2018 Animal Health Summit on Monday,
        February 26, 2018 at 3:15 p.m. ET. The conference will be held at the
        Bank of America Tower in New York City.
    --  Raymond James 39(th) Annual Institutional Investors Conference on
        Monday, March 5, 2018 at 11:35 a.m. ET. The conference will be held at
        the JW Marriott Orlando Grande Lakes Hotel in Orlando, Florida.

About Abaxis

Abaxis, Inc. is a worldwide developer, manufacturer and marketer of portable blood analysis systems that are used in a broad range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements. Our mission is to improve the efficiency of care delivery to and the quality of life of patients in the medical and veterinary markets. We provide leading edge technology and tools that support best medical practices, enabling physicians and veterinarians to respond to the health needs of their clients at the point of care while operating economical and profitable practices. For more information, visit http://www.abaxis.com.


    Contact: Clint Severson           Lytham Partners, LLC

             Chief Executive Officer Joe Dorame, Joe Diaz & Robert Blum

             ABAXIS, Inc.            602-889-9700

             510-675-6500

View original content:http://www.prnewswire.com/news-releases/abaxis-inc-to-present-at-the-bank-of-america-merrill-lynch-animal-health-summit-and-the-raymond-james-39th-annual-institutional-investors-conference-300602516.html

SOURCE Abaxis, Inc.